HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • Will Improving Adherence Optimize Medication Use?
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence and Access Marketplace
    • Visite the Marketplace
    • On-demand Webinar
  • Industry Events
    • HealthEconomics.Com Webinars
    • View Conferences
    • View Webinars
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute
You are here: Home / Archives for Industry News

Panalgo Releases RWD Benchmarking Report

Healthcare analytics company Panalgo released its 2021 State of Healthcare Analytics Benchmarking Report, featuring insight into the use of RWD (real world data). The report was based on an in-depth survey on how life sciences companies utilize RWD by Fierce Pharma. The authors also discuss barriers […]

more info 02/25/2021View Related Articles
Bookmark and Share

Icon Acquires PRA Health Sciences for $12 Billion

The use of decentralized trials has surged during COVID-19. CRO (contract research organization) Icon is set to acquire PRA Health Sciences. This will bring big changes to CROs and Icon is expected to direct anincreasing number of decentralized trials. “Icon, the Dublin-based CRO, will acquire […]

more info 02/25/2021View Related Articles
Bookmark and Share

Reference Pricing Could Negatively Affect Vulnerable Populations

Some countries use QALYs (Quality-Adjusted Life Years) to assess whether or not to use a treatment or prescription drug. The authors note this approach would bring negative consequences for people with chronic illness, people with disabilities, and older individuals in the United […]

more info 02/24/2021View Related Articles
Bookmark and Share

Webinar on Providing Meaningful Price Transparency Information

In order to comply with recent rulings, many organizations are sharing large amounts of data. However, not all data is necessary or even desired. Join this webinar to hear more about what consumers want to know—and what they don’t. Alison Greco of HealthSparq will share her insights. The webinar […]

more info 02/24/2021View Related Articles
Bookmark and Share

Using RWE to Make Cost Decisions: A New Report

A recent article, published in JMCP (the Journal of Managed Care and Specialty Pharmacy), considers how RWE (real world evidence) can be utilized when making economic decisions. ICER (the Institute for Clinical and Economic Review) has incorporated RWE in making its recommendations, but few other […]

more info 02/24/2021View Related Articles
Bookmark and Share

Payer Engagement Summit Videos on RWD Now Available

ISPOR held its first Payer Engagement Summit in 2020 to discuss the issues facing payers worldwide. The Summit featured discussions regarding the use of RWD (real world data). Payers face unique challenges when considering the use of RWD. Invited speakers included Fran Cunningham of the US […]

more info 02/24/2021View Related Articles
Bookmark and Share

COVID-19 CARE Registry Provides Informative Data

Dr. Nancy Dreyer is the Chief Scientific Officer of IQVIA Real World Solutions. In a recent interview led by Dr. Patti Peeples, CEO of HealthEconomics.Com and Vice President of Evidence and Content at Scientist.com, the scientists discussed how IQVIA has taken on COVID-19. The CARE (COVID Active […]

more info 02/24/2021View Related Articles
Bookmark and Share

Syapse Invests $68 Million in Expanding RWE to Improve Outcomes for Cancer Patients

Leading RWE (real world evidence) company Syapse has invested $68 million in a venture with Ally Bridge Group and Northpond Ventures. Syapse will expand its Learning Health Network. The overall goal is to improve outcomes for oncology patients. Additional goals are to reduce costs and to enhance […]

more info 02/23/2021View Related Articles
Bookmark and Share

Telehealth Brings Change to Traditional Clinical Visit—and Billing

The start of the COVID-19 pandemic brought many changes to the conventional doctor’s visit. A report by McKinsey found that telehealth adoption rose from 11% to now 46%. Healthcare providers are seeing between 50 and 175 times the patients via telehealth. Continuous remote patient monitoring makes […]

more info 02/23/2021View Related Articles
Bookmark and Share

What Does the FDA Think About RWE?

A year into the COVID-19 pandemic, the use of RWE in clinical study design is becoming more widespread. In a recent informative dialogue, Dr. Nancy Dreyer of IQVIA spoke with Dr. Amy Abernethy of the FDA regarding the different types of data included under the RWE umbrella. Dr. Abernethy provides […]

more info 02/23/2021View Related Articles
Bookmark and Share

As Pandemic Slows, Will Pfizer Increase Vaccine Price?

Pfizer is charging the United States $19.50 per dose of its new vaccine to prevent COVID-19. Pfizer CFO Frank D’Amelio considers this “pandemic pricing.” He notes that a typical price for a vaccine produced by Pfizer is around $150 to $175. He expects the price for Pfizer’s COVID-19 vaccine to rise […]

more info 02/23/2021View Related Articles
Bookmark and Share

Upcoming Webinar on COVID-19 Therapeutics and Vaccines

An upcoming webinar will review the data behind treatments for COVID-19, as well as vaccines that have received FDA emergency use approval. There are currently several treatments that are being evaluated by the FDA. This will be an informative event for many audiences, especially pharmacists in […]

more info 02/23/2021View Related Articles
Bookmark and Share

Good News: RWE Shows Effectiveness of COVID-19 Vaccines

A recent study examines how the vaccines produced by Moderna and Pfizer might protect against COVID-19. RWE (real world evidence) shows that these vaccines are broadly effective—both in preventing infection and reducing incidence of serious disease. The Pfizer vaccine is 95% effective and the […]

more info 02/22/2021View Related Articles
Bookmark and Share

Importing Prescription Drugs: What Does Biden Think?

According to former President Trump and current President Biden, Americans should be able to buy prescription drugs from other countries. Despite Biden’s assurances, skepticism remains high. Florida attempted to implement a prescription drug importation program, but faced serious issues. A $30 […]

more info 02/22/2021View Related Articles
Bookmark and Share

A Conversation With Ge Bai Regarding Amazon’s Pharmacy Foray

In a recent podcast with Dr. Ge Bai of Johns Hopkins, important points are discussed relating to Amazon’s venture into the pharmacy space. Her extensive background in in public health and business make for an informative discussion. She discusses PBMs (pharmacy benefit managers) and the reasons […]

more info 02/22/2021View Related Articles
Bookmark and Share

Do Hospitals Actually Mark Up Medications 250%?

A recent report examines the cost differences regarding medications in hospitals. A comparison across two dozen drugs led to the finding that the markup is an average of 250%. Over 30% of the hospitals included in the analysis did not stock biosimilars for the drugs analyzed. Although insurance […]

more info 02/22/2021View Related Articles
Bookmark and Share

HealthEconomics.Com’s Value and Evidence Marketplace Seeking Organizations With EHR Data

The Value and Evidence Marketplace is an online tool that matches biomedical and biopharmaceutical researchers with suppliers for research. 24 of the top 30 pharmaceutical companies, along with over 75 biotech companies, utilize our Marketplaces in their studies. Clients are increasingly interested […]

more info 02/22/2021View Related Articles
Bookmark and Share

Report on Impact of COVID-19 on Global Bioinformatics Market

A recent report discusses how COVID-19 affected the Bioinformatics Market. The impacts on five currencies (USD, EUR, AUD, GBP, JPY) are discussed. Chemoinformatics, genomics, proteomics, metabolomics, and transcriptomics were discussed, among other categories. The report addressed market […]

more info 02/19/2021View Related Articles
Bookmark and Share

Prediction Models for COVID-19 Can’t Account for All Human Elements

Early in the COVID-19 pandemic, researchers were scrambling to predict how the disease would spread. One such model was developed at the University of Illinois, Urbana-Champaign, by two physicists: Nigel Goldenfeld and Sergei Maslov. They were able to adapt some of the tools used in their physics […]

more info 02/19/2021View Related Articles
Bookmark and Share

Amalgam Rx, Inc. Acquires Avhana Health

Amalgam Rx. Inc. has acquired Avhana Health, a clinical decision support company with experience in electronic health records. This move will allow Amalgam Rx to build on Avhana’s existing tools and to expand into additional therapeutic areas. The result will be a simplified workflow for […]

more info 02/19/2021View Related Articles
Bookmark and Share

Meta-Analysis Study on Kidney Cancer Utilizes Novel Techniques to Identify Biomarkers

The survival rates of patients with kidney cancer largely depend on identifying biomarkers. The identification of these biomarkers can help determine a course of treatment. A recent study, published in JAMA, compares data from 6 clinical trials and reported in 9 publications. The report examined how […]

more info 02/19/2021View Related Articles
Bookmark and Share

Caesarean Section Procedure Can Vary in Price From 6k to 60k—At the Same Hospital

Women who undergo a caesarean section at the Van Ness site of the Pacific Medical Center in California might be surprised to find that the cost of their procedure may be vastly different from that of another woman in the same hospital. Costs range from $6,241 to $60,584 for this particular […]

more info 02/19/2021View Related Articles
Bookmark and Share

Webinar: Reflections on Healthcare in 2020 and Visions for 2021

In a recent webinar, the authors discuss important changes and developments in 2020 regarding healthcare regulations. The fast pace of change is expected to continue through 2021. The No Surprises Act passed in December 2020, meant to address unexpected medical bills, will bring changes to a diverse […]

more info 02/18/2021View Related Articles
Bookmark and Share

Webinar on RWE and Progress During COVID-19 Pandemic

The COVID-19 Pandemic has driven many researchers to incorporate RWE (real world evidence) into clinical trials. However, it can often be challenging to accomplish this task. In this webinar, Sandy Leonard and Akiko Shimamura of HealthVerity discuss advances regarding RWE in clinical trials. “The […]

more info 02/18/2021View Related Articles
Bookmark and Share

Using Bayesian Methods in Control Arms of Clinical Trials

The use of single arm trials has become more widespread, especially as the COVID-19 has forced clinical trials to change or end early. An alternative approach is the use of synthetic control arms (SCAs), arms that can be created using Bayesian Dynamic Borrowing. In this method, data from patients […]

more info 02/18/2021View Related Articles
Bookmark and Share

New Report Details How SDOH Impact Access to Prescription Drugs

In a recent report, CoverMyMeds discusses how SDOH (social determinants of health) are associated with many patients being forced to make difficult choices when it comes to their health. The COVID-19 pandemic has made these choices even more challenging as more Americans become uninsured or […]

more info 02/18/2021View Related Articles
Bookmark and Share

6 Recommendations Regarding HTAs in the United States

A whitepaper was recently released by researchers at the USC Schaeffer Center and the Aspen Institute. The authors discuss half a dozen recommendations relating to HTAs (Health Technology Assessments) in the United States, which could lead to changes in the pricing of prescription drugs. […]

more info 02/18/2021View Related Articles
Bookmark and Share

A Conversation with Peter Pitts on Drug Pricing and Medicare

In a recent podcast by Patients Rising Podcast, the hosts spoke with Peter Pitts. He co-founded and is currently president of the Center for Medicine in the Public Interest. He’s also served as Associate Commissioner for External Relations for the FDA, written a book on successful leadership, and […]

more info 02/17/2021View Related Articles
Bookmark and Share

Outcry Over Nick Jonas in Super Bowl Commercial for Dexcom

Type 1 Diabetics typically check their blood glucose levels by pricking their finger with a needle to obtain a small blood sample. Insulin injections regulate this blood glucose level, but can cause significant financial hardship. In a Super Bowl commercial for Dexcom, Nick Jonas promoted an […]

more info 02/17/2021View Related Articles
Bookmark and Share

Will a Committee Lead to Reduced Drug Prices in the United States?

Will a Committee Lead to Reduced Drug Prices in the United States The idea of an independent review board to regulate drug prices is gaining ground. Although pharmaceutical companies protest such a committee, pointing at lost innovation, many in the US support a Health Technology Assessment (HTA) […]

more info 02/17/2021View Related Articles
Bookmark and Share

  • 1
  • 2
  • 3
  • …
  • 245
  • Next Page

 

View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Conference of the Week:

Link of the Week:

Job of the Week:

Webinar of the Week:

White Papers

  • Health Technology Assessment in the U.S. – A Vision for the Future
  • Follow the Dollar Part II
  • 3 Steps for Building your SDOH Business Case
  • New Paths in Predictive Payer Coverage: Insights drawing from historical metrics that optimize pre- and post-commercialization marketing efforts for new therapies
  • 2021 Medication Access Report
  • Navigating forward: Whole-person care for better health
  • Navigating forward: A look back and look forward
  • Transforming Healthcare with Automated Machine Learning
  • The Gene Therapy Transformation: A Guide for Managed Care Decision Makers Web Activity
  • How to Mitigate Revenue Cycle Risk During an EHR Implementation
  • Case Study: Bending the Cost Trend for Medicare Advantage Members
  • Responding to COVID-19 with Data: Success Stories
  • How Successful Organizations are Addressing Cost Issues with Data
  • Addressing Revenue Challenges Using Data: Success Stories
  • Data-informed Care Transformation: Five Success Stories
  • Next-Generation Value-Based Payment Strategies
  • 2021 Outlook: Five Themes That Will Define Co-Pay Assistance
  • Take your market access to the next level: your free digital transformation eBook
  • How Healthy Are Your Market Access Programs? A guide to performing check-ups on pharmaceutical distribution and patient access programs
  • Data removes the barriers to understanding rare disease
  • The Future Was Today
  • How Can a Supply Chain Dashboard Yield Greater Clinical Trial Insights, Cost Control, and Efficiency?
  • Strategies for Engaging Vulnerable Populations in Healthcare
  • Tracing the health care experience informs decision-making
  • Driving More Value and Cost Savings With SDOH Data
  • Advancing Early Stage Oncology Research with Adaptive Designs and Master Protocols
  • Transformation of Clinical Trial Design and Operations
  • Using real-world data to close the rare disease data gap
  • Analysis and Insights from Real-World Clinical Registries: RA, GCA, JIA, & SLE
  • Aetion’s new eBook – The role of real-world evidence in FDA approvals

Syndicated Reports

  • Healthcare Trends & Forecasts in 2021: Performance Expectations for the Healthcare Industry
  • Medical Affairs Outsourcing Market 2021 Overview, Trends, Size, Growth and 2028 Future Insights
  • Bioinformatics Market Research Report by Product, by End User – Global Forecast to 2025 – Cumulative Impact of COVID-19
  • Health Economics & Outcomes Research (HEOR) Services Market to 2027
  • Healthcare Artificial Intelligence Market by Product and Services – Global Forecast to 2027
  • Bioinformatics Market – Growth, Share, Opportunities & Competitive Analysis, 2020 – 2028
  • Big Data and AI in Market Access
  • Altruista Health Payer Index Survey 2020 Report
  • Innovations in Drug Pricing and Reimbursement 2020
  • Healthcare Reimbursement Market Value forecast, New Business Opportunities and Companies: Outlook by Type, Application, by End User and by Country, 2020-2026
  • Real World Data for Orphan Drugs: Meeting the Data Analysis Challenge
  • Directory of Health Plans: Trusted Health Insurance Plan Enrollment and Affiliation Data
  • Global Value-Based Reimbursement Software Market Report
  • Health Economics & Outcomes Research (HEOR) Services Market: Emerging industries, Challenges and Threats Faced by Key Vendors(Axtria, Avalon Health Economics, Cardinal Health, ICON, IQVIA, McKesson, MEDLIOR, Optum, PharmaLex, (PPD), RTI)
  • World Preview 2019, Outlook to 2024
  • Provider Perceptions of Value-Based Care
  • Healthcare Industry’s Response to COVID-19
  • Value-Based Care Assessment
  • Pharmacy Benefit Management Market in US – Industry Outlook and Forecast 2020-2025
  • 2025 Growth: Healthcare Reimbursement Market set to grow with massive rate by 2020 to 2025
  • Global Specialty Pharmaceutical Market 2020- Pfizer, Roche, Amgen, AbbVie
  • 3 Trends to Accelerate Time to Market
  • Scientific Research And Development Services Global Market Report 2020-30: Covid 19 Impact and Recovery
  • Engaging with ICER: Lessons and insights for pharma
  • COVID-19 Implications for pharma: US payer insights
  • Pricing and Reimbursement in Oncology
  • Digital Technologies: New Strategies for Customer Engagement
  • Real World Evidence (RWE) Solutions Market by Component, Application, End User – Global Forecast to 2024
  • 2019 Healthcare Benchmarks: Social Determinants of Health
  • Pricing Transparency in Pharma
HealthEconomics.Com

HealthEconomics.Com

  • Become a Better Writer!
  • HealthEconomics.Com Recognized as Top Influencer at ISPOR International Meeting in Washington DC
  • Will ICER Framework Destroy Progress Against Multiple Myeloma?
  • Celgene Unleashes the Power of Data into Clinical Trial Design
  • How Well is Harvoni Working in the Real World?
  • New CVS and Express Scripts Value Based Plans for Oncology
  • Oversized Cancer Drug Vials Waste $3B Each Year
  • Can More Data Make Providers’ Jobs Easier?
  • News
  • Conferences
  • Reports
  • Jobs
  • Consulting
  • Newsletters
  • White Papers

More Links

  • Take This Survey for a Chance to Win $200!
  • Jobs
  • Education
  • Graduate Schools
  • Webinar Services

Support & Contact

  • ICER Releases Two Draft Reports on Obeticholic Acid
  • What do Patient Advocates Think of New ICER Report?
  • Could a New ICER Report Put Patients at Risk?
  • Contact Us

About

  • International Myeloma Foundation Responds to ICER Report
  • About Us
  • Advertise
  • Webinar Services
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HE Institute

Strategy, Training, Education, and Communications in HEOR & Market Access.

Innovation Webinar

Big ideas accelerating change in HEOR, RWE and Health Technology. Learn more!

tHEORetically Speaking Blog

Insights and observations for HEOR, market access, pricing, reimbursement, and health policy.

HE Jobs Portal

Your Premier Employment Source for HEOR, Market Access, and Real World Evidence

HE Webinars

Online educational and informational seminars for HEOR, market access, pricing, and reimbursement.
  • Doctor Evidence Launches GROWTH Replicator Program
  • Is PCORI Underfunding CER?
  • HealthEconomics.Com
  • About HealthEconomics.Com
  • Advertising Inquiries
  • Careers
  • Contact HealthEconomics.Com

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • Will Improving Adherence Optimize Medication Use?
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence and Access Marketplace
    • Visite the Marketplace
    • On-demand Webinar
  • Industry Events
    • HealthEconomics.Com Webinars
    • View Conferences
    • View Webinars
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute